(28f) Optogenetic-Mediated Preconditioning As a Novel Approach to Protect Cells from Stress-Induced Injury
AIChE Annual Meeting
2023
2023 AIChE Annual Meeting
Food, Pharmaceutical & Bioengineering Division
Poster session: Engineering Fundamentals in Life Science
Monday, November 6, 2023 - 3:30pm to 5:00pm
To overcome these limitations, our lab developed a next-generation mitochondrial-targeted optogenetic technology (mOpto) by expressing light-gated channelrhodopsin proteins specifically in the inner membrane of mitochondria. We hypothesized that mOpto-mediated mild and transient MMP depolarization could protect cells against stress-induced injury. To test this hypothesis, AC16 cells expressing the mOpto gene were illuminated with short-term, low-intensity (3 hours, 0.2 mW/mm2) blue light (470nm) to induce mild transient MMP depolarization, followed by exposing to various stressors such as FCCP (20 μM, 24 hours), H2O2 (200 μM, 24 hours), or ischemia-reperfusion (I2/R4: glucose-free medium and 0% O2 for 2 hours, and complete culture medium and oxygenated for 4 hours). At the end of the experiment, cell viability, ROS (reactive oxygen species) levels, and membrane potential were measured to determine the preconditioning-mediated cytoprotective effect. Additionally, we added mitoQ, a mitochondrial-specific antioxidant, to the preconditioning cells to examine the involvement of ROS in mOpto-mediated preconditioning.
Our results showed that MMP recovered completely within the light intensity range used for preconditioning, indicating its reversibility. We also observed significantly higher cell viability in the preconditioning group compared to the control groups in I2/R4, along with reduced ROS levels and partially recovered MMP. Similarly, preconditioning improved cell injury and mitochondrial dysfunction in FCCP and H2O2 treated cells. Finally, mitoQ had negligible effects on mOpto-mediated cytoprotective effects.
In summary, our study revealed that mOpto-mediated mild and transient mitochondrial depolarization effectively protects cells from various types of stress. Furthermore, our results suggest that the cytoprotective pathway engaged in this process is not dependent on ROS signaling. Although future mechanistic studies are warranted, our findings highlight the potential of mOpto-mediated preconditioning as a promising strategy to enhance the therapeutic value of engineered cells and deepen our understanding of cellular stress responses.